Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis (Q39123675)

9 September 2017

0 references

Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis (English)

1 reference

9 September 2017

1 reference

1 reference

Yantian Cao

1

1 reference

9 September 2017

Zhen Ding

2

1 reference

9 September 2017

Chaoqun Han

3

1 reference

9 September 2017

Huiying Shi

4

1 reference

9 September 2017

Lianlian Cui

5

1 reference

9 September 2017

Rong Lin

6

1 reference

9 September 2017

6 February 2017

1 reference

Digestive Diseases and Sciences

9 September 2017

1 reference

9 September 2017

62

1 reference

9 September 2017

4

1 reference

9 September 2017

851-860

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-017-4453-x

9 September 2017

0 references

cites work

Perianal Crohn's disease: overview.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Mechanisms of Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

The risk of cancer in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

In Vitro Conditioned Bone Marrow-Derived Mesenchymal Stem Cells Promote De Novo Functional Enteric Nerve Regeneration, but Not Through Direct-Transdifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Association of Age at Menopause and Duration of Reproductive Period With Depression After Menopause: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Cell therapy of refractory Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Management of internal fistulas in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Management of Complex Perineal Fistula Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Incontinence rates after cutting seton treatment for anal fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Outcome of surgical treatment for fistula in ano in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Crohn's fistula: current concepts in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-017-4453-X

Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem Cells

21 January 2018

1 reference

12 December 2020

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

1 reference

12 December 2020

Risk factors of colorectal cancer in inflammatory bowel disease.

1 reference

12 December 2020

Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

12 December 2020

American Gastroenterological Association medical position statement: perianal Crohn's disease

1 reference

12 December 2020

Current management of anal fistulas in Crohn's disease

1 reference

12 December 2020

Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial.

1 reference

12 December 2020

Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease

1 reference

12 December 2020

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

1 reference

12 December 2020

Recurrent anal fistulae: limited surgery supported by stem cells.

1 reference

12 December 2020

Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial.

1 reference

12 December 2020

10.1007/S10620-017-4453-X

Identifiers

DOI

1 reference

9 September 2017

1 reference